Julie C.

Julie C. has a diverse work experience starting in 2019. Julie worked as a Graduate Teaching Assistant at Imperial College London, where they assisted with teaching responsibilities. Julie also worked as a Postgraduate Research Assistant, conducting research on Type 2 Diabetes susceptibility genes.

In 2021, Julie C. joined Phenopolis as a Junior Consultant, where they provided grant writing assistance for the company's Innovative UK grant application. Their role also involved ensuring the safety of Health IT Systems through the application of NHS clinical risk management.

In 2022, Julie C. joined Candriam as an ESG Analyst in their graduate program. Here, they analyzed and selected biotechnology companies, their clinical programs, and assessed their viability and success. Julie also analyzed specific disease settings.

Julie C.'s most recent position is as a Commercial Analyst at Garvan Institute of Medical Research, which they started in 2023.

Julie C. has a diverse education history. Julie recently attended Vlerick Business School in 2022 and studied Asset Management. Before that, from 2020 to 2021, they pursued a Master of Science (MSc) degree in Bioscience Entrepreneurship from UCL. In 2018 and 2019, Julie obtained a Master's degree in Human Molecular Genetics from Imperial College London. Their undergraduate education took place from 2015 to 2018 at the University of Exeter, where they completed a Bachelor's degree in Cellular and Molecular Biology.

In addition to their academic achievements, Julie holds two additional certifications. In 2020, they became a certified Open Water Diver through PADI. Furthermore, in 2015, they obtained a certificate in The International English Language Testing System (IELTS) from The IELTS TOEFL Centre.